I Hate Dialysis Message Board
Welcome, Guest. Please login or register.
November 26, 2024, 02:26:27 PM

Login with username, password and session length
Search:     Advanced search
532606 Posts in 33561 Topics by 12678 Members
Latest Member: astrobridge
* Home Help Search Login Register
+  I Hate Dialysis Message Board
|-+  Dialysis Discussion
| |-+  Dialysis: News Articles
| | |-+  Certain antihypertensive medications are better at preventing cardiovascular dis
0 Members and 2 Guests are viewing this topic. « previous next »
Pages: [1] Go Down Print
Author Topic: Certain antihypertensive medications are better at preventing cardiovascular dis  (Read 2212 times)
okarol
Administrator
Member for Life
*****
Offline Offline

Gender: Female
Posts: 100933


Photo is Jenna - after Disneyland - 1988

WWW
« on: November 14, 2013, 11:29:52 PM »

Clinical / American Society of Nephrology (ASN) Kidney Week / Top News Stories
Certain antihypertensive medications are better at preventing cardiovascular disease in dialysis patients than others
NOVEMBER 13, 2013 No Comments

Among dialysis patients with hypertension and thickened heart muscles, certain antihypertensive medications are better than others for preventing cardiovascular disease and hospitalizations, according to an abstract, "Hypertension in Hemodialysis Patients Treated with Atenolol or Lisinopril (HDPAL): A Randomized Controlled Trial" (Abstract 5826), presented at the American Society of Nephrology's Kidney week 2013. A team led by Rajiv Agarwal, MD, MBBS, FASN, from the VA Medical Center in Indianapolis, conducted a clinical trial to assess the safety and efficacy of an ACE inhibitor–based antihypertensive treatment compared with a β-blocker-based antihypertensive treatment. Two hundred patients on hemodialysis who had hypertension and thickened heart muscles were randomized to the ACE inhibitor lisinopril or the β-blocker atenolol, each administered three times weekly after dialysis.

(Combining blood pressure drugs inked to serious side effects in type 2 diabetes patients)

Blood pressure improved over time in both groups, and no statistical difference between drugs was noted. An independent data safety monitoring board recommended termination of the study due to safety concerns. Serious cardiovascular events occurred in 14 patients in the atenolol group and 26 patients in the lisinopril group. Hospitalizations for heart failure and other causes were worse in the lisinopril group.

“Contrary to the original hypothesis, the trial found that among kidney dialysis patients with hypertension and thickening of heart muscles, atenolol-based antihypertensive therapy may be superior to lisinopril-based therapy in preventing cardiovascular disease such as heart failure and heart attacks as well as all-cause hospitalizations,” said Dr. Agarwal.

http://www.nephrologynews.com/articles/109872-certain-antihypertensive-medications-are-better-at-preventing-cardiovascular-disease-in-dialysis-patients-than-others
Logged


Admin for IHateDialysis 2008 - 2014, retired.
Jenna is our daughter, bad bladder damaged her kidneys.
Was on in-center hemodialysis 2003-2007.
7 yr transplant lost due to rejection.
She did PD Sept. 2013 - July 2017
Found a swap living donor using social media, friends, family.
New kidney in a paired donation swap July 26, 2017.
Her story ---> https://www.facebook.com/WantedKidneyDonor
Please watch her video: http://youtu.be/D9ZuVJ_s80Y
Living Donors Rock! http://www.livingdonorsonline.org -
News video: http://www.youtube.com/watch?v=J-7KvgQDWpU
Pages: [1] Go Up Print 
« previous next »
 

Powered by MySQL Powered by PHP SMF 2.0.17 | SMF © 2019, Simple Machines | Terms and Policies Valid XHTML 1.0! Valid CSS!